×
About 51,985 results

ALLMedicine™ Creatinine Center

Research & Reviews  17,680 results

TmP/GFR reference values from childhood to adulthood in the era of IDMS-standardized cr...
https://doi.org/10.1093/ndt/gfab331
Nephrology, Dialysis, Transplantation : Official Publicat... Dubourg LD, Aurelle M et. al.

Dec 2nd, 2021 - The assessment of phosphate homeostasis in clinical practice relies on circulating phosphate levels but also on phosphate tubular reabsorption, ideally assessed using the Tubular maximum Phosphate Reabsorption per Glomerular Filtration Rate (TmP/G...

Estimating urine volume from the urine creatinine concentration.
https://doi.org/10.1093/ndt/gfab337
Nephrology, Dialysis, Transplantation : Official Publicat... Dong Y, Silver SM et. al.

Dec 2nd, 2021 - Spot determinations of the urine creatinine concentration are widely used as a substitute for 24-hour urine collections. Expressed as the amount excreted per gram of creatinine, urine concentrations in a single-voided sample are often used to esti...

Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosi...
https://doi.org/10.1093/ndt/gfab335
Nephrology, Dialysis, Transplantation : Official Publicat... Wheeler DC, Jongs N et. al.

Dec 2nd, 2021 - Despite renin-angiotensin-aldosterone-system blockade and immunosuppressive treatment, focal segmental glomerulosclerosis (FSGS) often progresses to kidney failure. The objective of this pre-specified analysis of DAPA-CKD was to assess efficacy an...

see more →

Guidelines  4 results

2019 update of the European AIDS Clinical Society Guidelines for treatment of people li...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754379
HIV Medicine; Ryom L, Cotter A et. al.

Sep 5th, 2020 - The European AIDS Clinical Society (EACS) Guidelines cover key aspects of HIV management with major updates every two years. The 2019 Guidelines were extended with a new section focusing on drug-drug interactions and other prescribing issues in pe...

KDIGO 2012 Clinical Practice Guideline CKD classification rules out creatinine clearanc...
https://doi.org/10.1016/j.clinbiochem.2015.07.030
Clinical Biochemistry; Ognibene A, Grandi G et. al.

Aug 2nd, 2015 - The recent guideline for the evaluation and management of Chronic Kidney Disease recommends assessing GFR employing equations based on serum creatinine; despite this, creatinine clearance 24-hour urine collection is used routinely in many settings...

Canadian Association of Radiologists consensus guidelines for the prevention of contras...
https://doi.org/10.1016/j.carj.2012.11.002
Canadian Association of Radiologists Journal = Journal L'... Owen RJ, Hiremath S et. al.

Feb 25th, 2014 - Contrast-induced acute kidney injury or contrast-induced nephropathy (CIN) is a significant complication of intravascular contrast medium (CM). These guidelines are intended as a practical approach to risk stratification and prevention. The major ...

Clinical guideline for male lower urinary tract symptoms.
https://doi.org/10.1111/j.1442-2042.2009.02369.x
International Journal of Urology : Official Journal of Th... Homma Y, Araki I et. al.

Oct 9th, 2009 - This article is a shortened version of the clinical guideline for lower urinary tract symptoms (LUTS), which has been developed in Japan for symptomatic men aged 50 years and over irrespective of presumed diagnoses. The guideline was formed on the...

see more →

Drugs  524 results see all →

Clinicaltrials.gov  998 results

A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease
https://clinicaltrials.gov/ct2/show/NCT04492722

Nov 25th, 2021 - The study will be conducted in approximately 118 study centers across 12 countries. The overall study period will be around 28 weeks. Approximately 632 participants comprising of 67% diabetic kidney disease (DKD) and 33% non-DKD participants will ...

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04933539

Nov 25th, 2021 - Background: Smoldering multiple myeloma (SMM) is a precursor condition to MM defined by the clinical parameters of M-protein >=3.0 g/dL or bone marrow plasma cells >=10%, and absence of end organ disease. Patients with high-risk SMM have a risk of...

Trifecta-Kidney cfDNA-MMDx Study
https://clinicaltrials.gov/ct2/show/NCT04239703

Nov 25th, 2021 - There is a need for better screening of kidney transplant patients for rejection. Patients with kidney transplants are routinely tested (creatinine, urine protein, histology and donor specific antibody (DSA) as standard of care to detect rejection...

Pressure Support Ventilation Versus Continuous Positive Air Way Pressure (CPAP) Using I Gelin Adult Patients,
https://clinicaltrials.gov/ct2/show/NCT05116839

Nov 19th, 2021 - Patients and Methods This prospective,cross over study will be conducted after obtaining approval from the Institutional Review Board (IRB) of faculty of medicine Mansoura University. A written informed consent will be obtained from all participan...

Transcatheter Para-Valvular Leak Closure: An International Prospective Multicentre Registry
https://clinicaltrials.gov/ct2/show/NCT05089136

Nov 19th, 2021 - Prosthetic paravalvular leaks (PVL) are associated with congestive heart failure and haemolysis, for which the standard treatment is open-heart surgery with the attendant risks to the patient. Transcatheter closure has emerged as an alternative. P...

see more →

News  1,569 results

Case: Older patient with T2D has recurrent flushing
https://www.mdedge.com/internalmedicine/article/248875/geriatrics/case-older-patient-t2d-has-recurrent-flushing
Douglas S. Paauw, MD

Nov 18th, 2021 - A 64 year-old man with type 2 diabetes complains of recurrent flushing for the past 6 months. He has had no other symptoms.

Rituximab, Cyclophosphamide Similar for Inducing EGPA Remission
https://www.medscape.com/viewarticle/963134

Nov 17th, 2021 - Rituximab didn't perform any worse or better at inducing remission after a year in patients with eosinophilic granulomatosis with polyangiitis (EGPA) than did conventional treatment with cyclophosphamide in the phase 3 REOVAS trial conducted in Fr...

Cheap Diuretic, Chlorthalidone, Drops BP in Advanced Kidney Disease
https://www.medscape.com/viewarticle/962402

Nov 5th, 2021 - Twelve weeks of treatment with the thiazide diuretic chlorthalidone led to about an average 10 mmHg cut in systolic blood pressure in patients with treatment-resistant hypertension and advanced stage 4 chronic kidney disease in a randomized study ...

FDA Approves Companion Diagnostic for Adjuvant Atezolizumab in Stage II to IIIA NSCLC
https://www.onclive.com/view/fda-approves-companion-diagnostic-for-adjuvant-atezolizumab-in-stage-ii-to-iiia-nsclc

Oct 22nd, 2021 - The FDA has approved the VENTANA PD-L1 (SP263) assay to assist in identifying which adult patients with stage II to IIIA non–small cell lung cancer (NSCLC) whose tumors have PD-L1 expression on 1% or more of tumor cells are eligible to receive adj...

CKD and Cancer Risk: What's the Link?
https://www.medscape.com/viewarticle/960849

Oct 14th, 2021 - Takeaway Chronic kidney disease (CKD) diagnosed using estimated glomerular filtration rate cystatin C (eGFRcys) was associated with an increased risk of cancer incidence and cancer death. Why this matters Findings warrant future studies to evaluat...

see more →

Patient Education  19 results see all →